Houten, The Netherlands (PRWEB) May 30, 2012
Pioneer Surgical Technology, Inc., a leader in innovative medical devices, announces today the successful human implantation of nanOss Bioactive in Europe. The nanOss Bioactive bone graft utilizes proprietary nanocrystalline hydroxyapatite as well as a collagen-based biopolymer to promote bone growth in the posterolateral spine.
This new product portfolio will be showcased during the 2012 Spine Week Conference in Amsterdam, The Netherlands, on 28 May through 1 June.
Regarding Pioneer’s latest product introduction, Mr. Shane Ray, Executive Vice President- Biologics for Pioneer stated, “Once again we are pleased to announce further geographic expansion of our flagship product nanOss Bioactive. International expansion of our Biologics products is a strategic activity for Pioneer Surgical and complements the Pioneer spine products that are already available outside the United States.”
For more information regarding Pioneer’s Biologics product offerings, including nanOss Bioactive, please visit the Pioneer Surgical website at PioneerSurgical.com.
About Pioneer Surgical Technology, Inc.:
Pioneer Surgical, founded in 1992, is a dynamic, research-driven medical device company focused on delivering highly differentiated spine, orthopedic, cardiovascular, and biologic products. Pioneer is committed to the global advancement of innovative surgical technologies by designing products that provide better patient outcomes, efficient procedures for surgeons and operating room staff, and cost-effective solutions for the healthcare system.
Pioneer’s focus on innovation has resulted in over 130 U.S. and foreign patents, with numerous patents pending and employs more than 270 people worldwide.
Pioneer’s European subsidiary was established in the Netherlands in 2006. Pioneer offers a full range of spine products through several distributors throughout Europe.
For more information on Pioneer and its products, visit PioneerSurgical.com.